JW Life Science Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Life Science Corp with three other
companies in this sector in South Korea:
Whanin Pharmaceutical Company Limited
sales of 147.95 billion Korean Won [US$131.68 million]
of which 78%
was Riperidon &Quetapin etc.),
Bukwang Pharmaceutical Company Limited
(150.74 billion Korean Won [US$134.16 million]
of which 100%
was Pharmacy), and
Myungmoon Pharmaceutical Company Limited
(140.14 billion Korean Won [US$124.72 million]
of which 97%
was Manufacture and Sale of Pharmaceuticals).